Enriched Collagen With Natural Matrix
Biocompatible And Biodegradable
SynDerm
SynDerm is a Medical Technology company that specializes in advanced wound management. SynDerm’s product (Dermobor) is manufactured using advanced tissue engineering technology to create a unique Xenogenic Skin substitute for the treatment of hard to heal wounds.
About Synderm
SynDerm is a medical technology company focused on advanced treatments for hard to heal wounds، such as burn wounds. SynDerm’s property tissue engineering technology is clinically proven to improve the rate and speed of healing in deep and chronic wounds. The produced acellular xenogenic skin substitute dresses the wound and facilitates the epithelialisation by reduction of inflammation and infection and promotes cell proliferation and dead cells absorption. high tissue integrity due to similarities to extracellular matrix (ECM), biocompatibility and impregnation with minerals are the main positive points of SynDerm. Not immunogenicity and promotion of vascularization are the main advantages of this product..
Dr.Leila Roshangar
CEO/ Founder:
Professor of Anatomical Sciences, Post doc in Regenerative Medicine, Director of stem cell research center, 20 years of academic career.
Role: CEO
Need Help?
Contact Us info@Synderm.com Get 24/7
Tissue Engineered Skin
Based on the Tissue Engineered Skin Substitutes industrial chain, this report mainly elaborates the definition, types, application and major players of Tissue Engineered Skin Substitutes market in
details. Deep analysis about market status (2016-2021E), enterprise competition pattern, advantages and disadvantages of enterprise products, industry development trends (2021E-2026F), regional industrial layout characteristics and macroeconomic policies, industrial policy has also been included. From raw materials to downstream buyers of this industry will be analyzed
scientifically, the feature of product circulation and sales channel will be presented as well. In a word, this report will help you to establish a panorama of industrial development and characteristics of the Tissue Engineered Skin Substitutes market.
Introduction
Tissue engineering which is applied in regenerative medicine has three basic components: cells, scaffolds and growth factors. This multidisciplinary field can regulate cell behaviours in different conditions using scaffolds and growth factors.
Scaffolds can form an integral part of tissue engineering as an extracellular matrix for cell growth and proliferation. Decellularized biological scaffolds have several advantages over synthetic scaffolds, including being natural, easily available, and economical. They can be extracted from various tissues including ؛ the bladder, small intestine, liver and tracheal tissues.
Our results in SynDerm, indicated that the ultrastructure of the scaffold is maintained after the decellularization process and despite the low thickness of the scaffold, it had suitable mechanical resistance and shows acceptable stability. We hold that the scaffold could have the ability to expedite the repair and regeneration of wound management such as burns as a suitable skin dress.
